Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38242

BAHCC1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

BAHCC1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population generated from HEK293T human embryonic kidney epithelial cells. BAHCC1 is a BAH domain-containing chromatin-associated protein predicted to interact with histones, SWI/SNF chromatin remodeling complexes, and Polycomb group proteins, thereby influencing chromatin dynamics and transcriptional output. This knockout model is suited for applications including ChIP-qPCR for histone modification profiling, RNA-seq transcriptome analysis, western blotting, immunofluorescence, and co-immunoprecipitation to dissect epigenetic regulation, chromatin biology, and developmental mechanisms. Ascent Research offers further customization and technical support.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    BAHCC1

    Gene Identifier

    NCBI Gene ID 57597

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

BAHCC1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population disrupting the BAHCC1 gene in HEK293T cells, a robust human cell line. This knockout model enables functional studies of BAHCC1, a BAH domain-containing chromatin-associated protein. The polyclonal format preserves heterogeneous editing events, providing a robust tool for investigating gene function without clonal selection bias. Loss of BAHCC1 is expected to impair its chromatin interactions and downstream regulatory roles.

The parental HEK293T cell line originates from human embryonic kidney epithelial cells transformed with adenovirus 5 DNA and constitutively expressing SV40 large T antigen. This background confers high transfection efficiency and high-level protein expression, making HEK293T a preferred host for CRISPR-based genome engineering and diverse molecular biology applications. Its adherent epithelial morphology and robust proliferation are advantageous for cell-based assays.

BAHCC1 contains a BAH domain that likely recognizes specific histone modifications, thereby linking it to chromatin remodeling and transcriptional regulation. It is predicted to interact with core histones, the SWI/SNF chromatin remodeling complex, and Polycomb group proteins, thereby influencing chromatin structure and transcriptional output. Through these interactions, BAHCC1 may modulate chromatin accessibility and gene expression programs. Its knockout is anticipated to disrupt these epigenetic networks, although upstream regulators and downstream targets remain largely undefined.

In the HEK293T context, BAHCC1 knockout provides a tractable and well-characterized system to study epigenetic mechanisms in a transformed epithelial background. SV40 large T antigen may influence chromatin dynamics, offering a relevant model for exploring epigenetic dysregulation. The polyclonal formation captures editing diversity, making it suitable for bulk analyses where average knockout effects reflect biologically meaningful perturbations in chromatin organization and gene expression.

Key applications include ChIP-qPCR to assess histone modifications at specific loci, RNA-seq for transcriptome-wide expression changes, western blotting, immunofluorescence localization, and co-immunoprecipitation for protein interaction studies. This model supports research into chromatin dynamics, epigenetic regulation, transcriptional control, and developmental biology. Contact Ascent Research for further technical details, support, and customization options.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)